| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:307-313.)
© 2005 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From the Heart Center, Department of Electrophysiology, University of Leipzig, Leipzig, Germany.
Correspondence to Gerhard Hindricks, MD, University of Leipzig, Heart Center, Department of Electrophysiology, Strümpellstrasse 39, 04289 Leipzig, Germany. E-mail hindg{at}medizin.uni-leipzig.de
Received July 8, 2004; de novo received November 3, 2004; revision received March 30, 2005; accepted March 31, 2005.
Background The objective of this study was to assess the incidence and impact of asymptomatic arrhythmia in patients with highly symptomatic atrial fibrillation (AF) who qualified for radiofrequency (RF) catheter ablation.
Methods and Results In this prospective study, 114 patients with at least 3 documented AF episodes together with corresponding symptoms and an ineffective trial of at least 1 antiarrhythmic drug were selected for RF ablation. With the use of CARTO, circumferential lesions around the pulmonary veins and linear lesions at the roof of the left atrium and along the left atrial isthmus were placed. A continuous, 7-day, Holter session was recorded before ablation, right after ablation, and after 3, 6, and 12 months of follow-up. During each 7-day Holter monitoring, the patients recorded quality and duration of any complaints by using a detailed symptom log. More than 70 000 hours of ECG recording were analyzed. In the 7-day Holter records before ablation, 92 of 114 patients (81%) had documented AF episodes. All episodes were symptomatic in 35 patients (38%). In 52 patients (57%), both symptomatic and asymptomatic episodes were recorded, whereas in 5 patients (5%), all documented AF episodes were asymptomatic. After ablation, the percentage of patients with only asymptomatic AF recurrences increased to 37% (P<0.05) at the 6-month follow-up. An analysis of patient characteristics and arrhythmia patterns failed to identify a specific subset who were at high risk for the development of asymptomatic AF.
Conclusions Even in patients presenting with highly symptomatic AF, asymptomatic episodes may occur and significantly increase after catheter ablation. A symptom-onlybased follow-up would substantially overestimate the success rate. Objective measures such as long-term Holter monitoring are needed to identify asymptomatic AF recurrences after ablation.
Key Words: atrium ablation arrhythmia fibrillation follow-up studies
This article has been cited by other articles:
![]() |
D. G. Wyse Cardioversion of Atrial Fibrillation for Maintenance of Sinus Rhythm: A Road to Nowhere Circulation, October 6, 2009; 120(14): 1444 - 1452. [Full Text] [PDF] |
||||
![]() |
T. Hanke, E. I. Charitos, U. Stierle, A. Karluss, E. Kraatz, B. Graf, A. Hagemann, M. Misfeld, and H. H. Sievers Twenty-Four-Hour Holter Monitor Follow-Up Does Not Provide Accurate Heart Rhythm Status After Surgical Atrial Fibrillation Ablation Therapy: Up to 12 Months Experience With a Novel Permanently Implantable Heart Rhythm Monitor Device Circulation, September 15, 2009; 120(11_suppl_1): S177 - S184. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. T. Han, V. Kasirajan, M. Kowalski, R. Kiser, L. Wolfe, G. Kalahasty, R. K. Shepard, M. A. Wood, and K. A. Ellenbogen Results of a Minimally Invasive Surgical Pulmonary Vein Isolation and Ganglionic Plexi Ablation for Atrial Fibrillation: Single-Center Experience With 12-Month Follow-Up Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 370 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Halimi, L. Van Erven, and on behalf of the EHRA Scientific Initiatives Commi Validation of success following atrial fibrillation ablation: a European survey Europace, August 1, 2009; 11(8): 1002 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bertaglia, P. D. Bella, C. Tondo, A. Proclemer, N. Bottoni, R. De Ponti, M. Landolina, M. G. Bongiorni, L. Coro, G. Stabile, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMergeTM Italian Registry Europace, August 1, 2009; 11(8): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Edgerton, J. H. McClelland, D. Duke, M. W. Gerdisch, B. M. Steinberg, S. H. Bronleewe, S. L. Prince, M. A. Herbert, S. Hoffman, and M. J. Mack Minimally invasive surgical ablation of atrial fibrillation: Six-month results J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Pontoppidan, J C Nielsen, S H Poulsen, H K Jensen, H Walfridsson, A K Pedersen, and P S Hansen Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial Heart, June 15, 2009; 95(12): 994 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force members, M. Brignole, P. Vardas, E. Hoffman, H. Huikuri, A. Moya, R. Ricci, N. Sulke, W. Wieling, EHRA Scientific Documents Committee, et al. Indications for the use of diagnostic implantable and external ECG loop recorders Europace, May 1, 2009; 11(5): 671 - 687. [Full Text] [PDF] |
||||
![]() |
A. Verma Alternatives to amiodarone: search for the Holy Grail Europace, April 1, 2009; 11(4): 402 - 404. [Full Text] [PDF] |
||||
![]() |
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Camm and J. A. Reiffel Defining endpoints in clinical trials on atrial fibrillation Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H55 - H78. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al. Consensus document on antithrombotic therapy in the setting of electrophysiological procedures Europace, May 1, 2008; 10(5): 513 - 527. [Full Text] [PDF] |
||||
![]() |
D. Shah Atrial fibrillation burden: a 'hard' indicator of therapeutic efficacy and a prognostic marker to boot? Eur. Heart J., April 2, 2008; 29(8): 964 - 965. [Full Text] [PDF] |
||||
![]() |
D. Steven, T. Rostock, B. Lutomsky, H. Klemm, H. Servatius, I. Drewitz, K. Friedrichs, R. Ventura, T. Meinertz, and S. Willems What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring Eur. Heart J., April 2, 2008; 29(8): 1037 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Noheria, A. Kumar, J. V. Wylie Jr, and M. E. Josephson Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation: A Systematic Review Arch Intern Med, March 24, 2008; 168(6): 581 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Moreira, R. Manusama, C. Timmermans, B. Ghaye, S. Philippens, H. J.J. Wellens, and L.-M. Rodriguez Long-Term Follow-Up After Cryothermic Ostial Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation J. Am. Coll. Cardiol., February 26, 2008; 51(8): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pratola, E. Baldo, P. Notarstefano, T. Toselli, and R. Ferrari Radiofrequency Ablation of Atrial Fibrillation: Is the Persistence of All Intraprocedural Targets Necessary for Long-Term Maintenance of Sinus Rhythm? Circulation, January 15, 2008; 117(2): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Moreira, C. Timmermans, H. J.J. Wellens, Y. Mizusawa, S. Philippens, D. Perez, and L.-M. Rodriguez Can Common-Type Atrial Flutter Be a Sign of an Arrhythmogenic Substrate in Paroxysmal Atrial Fibrillation?: Clinical and Ablative Consequences in Patients With Coexistent Paroxysmal Atrial Fibrillation/Atrial Flutter Circulation, December 11, 2007; 116(24): 2786 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hindricks and H. Kottkamp From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation Eur. Heart J., December 1, 2007; 28(23): 2827 - 2829. [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA) Eur. Heart J., November 2, 2007; 28(22): 2803 - 2817. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association Europace, November 1, 2007; 9(11): 1006 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schmidt, S. Asbach, O. Schweika, M. Zehender, C. Bode, and T. S. Faber Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients Europace, September 1, 2007; 9(9): 812 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jais and D. L. Packer Ablation vs. drug use for atrial fibrillation Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G26 - G34. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Mehall, R. M. Kohut Jr, E. W. Schneeberger, W. H. Merrill, and R. K. Wolf Absence of Correlation Between Symptoms and Rhythm in "Symptomatic" Atrial Fibrillation Ann. Thorac. Surg., June 1, 2007; 83(6): 2118 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF] |
||||
![]() |
T. Okada, T. Yamada, Y. Murakami, N. Yoshida, Y. Ninomiya, T. Shimizu, J. Toyama, Y. Yoshida, T. Ito, N. Tsuboi, et al. Prevalence and Severity of Left Atrial Edema Detected by Electron Beam Tomography Early After Pulmonary Vein Ablation J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1436 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stulak, J. A. Dearani, T. M. Sundt III, R. C. Daly, C. G.A. McGregor, K. J. Zehr, and H. V. Schaff Superiority of cut-and-sew technique for the Cox maze procedure: Comparison with radiofrequency ablation J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1022 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jeanmart, F. Casselman, R. Beelen, F. Wellens, I. Bakir, F. Van Praet, G. Cammu, Y. Degriek, Y. Vermeulen, and H. Vanermen Modified Maze During Endoscopic Mitral Valve Surgery: The OLV Clinic Experience Ann. Thorac. Surg., November 1, 2006; 82(5): 1765 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
A Nergardh and M Frick Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation Heart, September 1, 2006; 92(9): 1244 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): 700 - 752. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030. [Full Text] [PDF] |
||||
![]() |
G. Y H Lip and A. Tello-Montoliu Management of atrial fibrillation. Heart, August 1, 2006; 92(8): 1177 - 1182. [Full Text] [PDF] |
||||
![]() |
T. Neumann, A. Erdogan, T. Dill, H. Greiss, A. Berkowitsch, J. Sperzel, M. Kuniss, K. Kurzidim, C. W. Hamm, and H.-F. Pitschner Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation Europace, July 1, 2006; 8(7): 495 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ad, S. Barnett, E. A. Lefrak, A. Korach, A. Pollak, D. Gilon, and A. Elami Impact of follow-up on the success rate of the cryosurgical maze procedure in patients with rheumatic heart disease and enlarged atria J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1073 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
D George Wyse Pulmonary vein isolation was better than antiarrhythmic drugs for symptomatic atrial fibrillation Evid. Based Med., February 1, 2006; 11(1): 16 - 16. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |